Literature DB >> 1977981

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

J J LiPuma1, S E Dasen, D W Nielson, R C Stern, T L Stull.   

Abstract

Ribotyping, a method of strain identification based on analysis of bacterial genomic restriction fragment length polymorphisms, was used to investigate the acquisition of Pseudomonas cepacia by a patient with cystic fibrosis. Analysis of isolates recovered from the index patient and his contacts showed person-to-person transmission of this opportunist organism. This documentation of the transmission of P cepacia from one cystic fibrosis patient to another suggests that measures to limit the acquisition of the pathogen by patients with cystic fibrosis may be worth while.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977981     DOI: 10.1016/0140-6736(90)92571-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  103 in total

1.  Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

Authors:  F E Clode; M E Kaufmann; H Malnick; T L Pitt
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Identification of members of the Burkholderia cepacia complex by species-specific PCR.

Authors:  P W Whitby; K B Carter; K L Hatter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 4.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

5.  Direct PCR detection of Burkholderia cepacia complex and identification of its genomovars by using sputum as source of DNA.

Authors:  Pavel Drevínek; Hana Hrbácková; Ondrej Cinek; Jana Bartosová; Otakar Nyc; Alexandr Nemec; Petr Pohunek
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

6.  Pseudomonas cepacia in cystic fibrosis.

Authors:  R Gold
Journal:  Can J Infect Dis       Date:  1993-05

7.  Epidemiology of Pseudomonas cepacia in cystic fibrosis.

Authors: 
Journal:  Can J Infect Dis       Date:  1993-05

8.  Unusual distribution of Burkholderia cepacia complex species in Danish cystic fibrosis clinics may stem from restricted transmission between patients.

Authors:  Niels Nørskov-Lauritsen; Helle Krogh Johansen; Mette G Fenger; Xiaohui C Nielsen; Tacjana Pressler; Hanne V Olesen; Niels Høiby
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

9.  Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients.

Authors:  Benjamin T Kopp; Basant A Abdulrahman; Arwa A Khweek; Surender B Kumar; Anwari Akhter; Richard Montione; Mia F Tazi; Kyle Caution; Karen McCoy; Amal O Amer
Journal:  Biochem Biophys Res Commun       Date:  2012-06-20       Impact factor: 3.575

10.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.